Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/14/21
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 12/31/29
Due: 12/31/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer | NCT05033392 | Wan He | user2@example.com | None | 2021-09-14 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III) | NCT06832917 | Wan He | user2@example.com | None | 2025-03-31 | 2029-12-31 | 2030-12-31 | - | - | 2025-07-14 |